1 – 83 of 83
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Article
-
Mark
Re : Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020
(
- Contribution to journal › Letter
-
Mark
What is a Bladder Cancer Molecular Subtype?
(
- Contribution to journal › Scientific review
-
Mark
The Lund taxonomy for bladder cancer classification – from gene expression clustering to cancer cell molecular phenotypes, and back again
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
(
- Contribution to journal › Article
-
Mark
A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification
(
- Contribution to journal › Article
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
-
Mark
Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
(
- Contribution to journal › Scientific review
-
Mark
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?
(
- Contribution to journal › Letter
-
Mark
Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours : An integrated immunohistochemical analysis
(
- Contribution to journal › Article
-
Mark
The Lund Molecular Taxonomy Applied to Non-Muscle-Invasive Urothelial Carcinoma
(
- Contribution to journal › Article
- 2021
-
Mark
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
(
- Contribution to journal › Article
-
Mark
When the Molecular Subtype Is Hidden Behind a Veil of Stroma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight
(
- Contribution to journal › Article
- 2020
-
Mark
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
(
- Contribution to journal › Article
-
Mark
Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer : A Step in the Right Direction but Still a Long Way To Go.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer
(
- Contribution to journal › Article
-
Mark
Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship
(
- Contribution to journal › Article
-
Mark
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer
(
- Contribution to journal › Article
-
Mark
Molecular pathology of the luminal class of urothelial tumors
(
- Contribution to journal › Article
- 2018
-
Mark
Molecular subtype classification of urothelial carcinoma in Lynch syndrome
(
- Contribution to journal › Article
-
Mark
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
(
- Contribution to journal › Article
-
Mark
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
(
- Contribution to journal › Article
-
Mark
A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort
(
- Contribution to journal › Article
-
Mark
Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases
(
- Contribution to journal › Article
- 2017
-
Mark
Frequent miRNA-convergent fusion gene events in breast cancer
(
- Contribution to journal › Article
-
Mark
HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts
(
- Contribution to journal › Article
-
Mark
Genetic Alterations in the Molecular Subtypes of Bladder Cancer : Illustration in the Cancer Genome Atlas Dataset
(
- Contribution to journal › Scientific review
-
Mark
Molecular classification of urothelial carcinoma : global mRNA classification versus tumour-cell phenotype classification
(
- Contribution to journal › Article
- 2016
-
Mark
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
(
- Contribution to journal › Article
-
Mark
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
(
- Contribution to journal › Article
-
Mark
Sätt fokus på blåscancer
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2015
-
Mark
Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.
(
- Contribution to journal › Article
-
Mark
Biological determinants of bladder cancer gene expression subtypes.
(
- Contribution to journal › Article
-
Mark
Reply from Authors re: Bas W.G. van Rhijn, Mark A. Behrendt, Kees Hendricksen, Theo H. van der Kwast. Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.03.030.
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Infiltration of CD3(+) and CD68(+) cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
(
- Contribution to journal › Article
- 2013
-
Mark
Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p.
(
- Contribution to journal › Article
-
Mark
Monitoring of technical variation in quantitative high-throughput datasets.
(
- Contribution to journal › Article
- 2012
-
Mark
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.
(
- Contribution to journal › Article
-
Mark
A Molecular Taxonomy for Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status.
(
- Contribution to journal › Article
-
Mark
The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles.
(
- Contribution to journal › Article
-
Mark
Molecular profiling reveals low- and high-grade forms of primary melanoma
(
- Contribution to journal › Article
- 2011
-
Mark
A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1.
(
- Contribution to journal › Article
-
Mark
Genotyping techniques to address diversity in tumors.
(
- Contribution to journal › Article
-
Mark
Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene.
(
- Contribution to journal › Article
- 2010
-
Mark
Robust assignment of cancer subtypes from expression data using a uni-variate gene expression average as classifier
(
- Contribution to journal › Article
-
Mark
Prediction of Stage, Grade, and Survival in Bladder Cancer Using Genome Wide Expression Data: A Validation Study.
(
- Contribution to journal › Article
-
Mark
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
(
- Contribution to journal › Article
- 2009
-
Mark
MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
(
- Contribution to journal › Article
-
Mark
Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.
(
- Contribution to journal › Article
- 2008
-
Mark
Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays
(
- Contribution to journal › Article
-
Mark
Tissue microarray based analysis of prognostic markers in invasive bladder cancer: Much effort to no avail?
(
- Contribution to journal › Article
-
Mark
Recurrent and multiple bladder tumors show conserved expression profiles.
(
- Contribution to journal › Article
- 2007
-
Mark
High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
(
- Contribution to journal › Article
-
Mark
Distinct mitotic segregation errors mediate chromosomal instability in aggressive urothelial cancers.
(
- Contribution to journal › Article
-
Mark
Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status.
(
- Contribution to journal › Article
-
Mark
Bladder cancer, a two phased disease?
(
- Contribution to journal › Scientific review
-
Mark
Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanoma.
(
- Contribution to journal › Article
- 2006
-
Mark
Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.
(
- Contribution to journal › Article
-
Mark
A gene fusion network in human neoplasia.
(
- Contribution to journal › Article
-
Mark
Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays.
(
- Contribution to journal › Article
- 2005
-
Mark
Ewing tumours and synovial sarcomas have critical features of karyotype evolution in common with epithelial tumours.
(
- Contribution to journal › Article
-
Mark
Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.
(
- Contribution to journal › Article
-
Mark
Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations
(
- Contribution to journal › Article
-
Mark
Connecting mitotic instability and chromosome aberrations in cancer-can telomeres bridge the gap?
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Dissecting karyotypic patterns in malignant melanomas: Temporal clustering of losses and gains in melanoma karyotypic evolution.
(
- Contribution to journal › Article
-
Mark
Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas.
(
- Contribution to journal › Article
- 2003
-
Mark
Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors
(
- Contribution to journal › Article
- 2002
-
Mark
Cyclin D1 amplification in chromosomal band 11q13 is associated with overrepresentation of 3q21-q29 in head and neck carcinomas.
(
- Contribution to journal › Article
-
Mark
Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma.
(
- Contribution to journal › Article
-
Mark
Dissecting karyotypic patterns in colorectal tumors: two distinct but overlapping pathways in the adenoma-carcinoma transition.
(
- Contribution to journal › Article
- 2001
-
Mark
Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH
(
- Contribution to journal › Article
-
Mark
Abnormal nuclear shape in solid tumors reflects mitotic instability
(
- Contribution to journal › Article
-
Mark
Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies
(
- Contribution to journal › Article
-
Mark
Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas
(
- Contribution to journal › Article
- 1998
-
Mark
Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization
(
- Contribution to journal › Article
-
Mark
A case of dermatofibrosarcoma protuberans with a ring chromosome 5 and a rearranged chromosome 22 containing amplified COL1A1 and PDGFB sequences
(
- Contribution to journal › Article
-
Mark
ETV6/ABL fusion is rare in Ph-negative chronic myeloid disorders
(
- Contribution to journal › Article